10:["$","main",null,{"role":"main","children":[["$","a",null,{"id":"main-content"}],["$","div",null,{"className":"inner","children":["$","div",null,{"className":"layout-content","children":["$","div",null,{"className":"region region-content","children":[["$","div",null,{"className":"hidden"}],["$","div",null,{"className":"block-carlyle-2026-mainpagecontent block block-system block-system-main-block","id":"block-carlyle-2026-mainpagecontent","children":["$","article",null,{"className":"node node--type-investment node--view-mode-full","children":["$","div",null,{"className":"node__content","children":[["$","div","0",{"dangerouslySetInnerHTML":{"__html":""}}],["$","div","1",{"dangerouslySetInnerHTML":{"__html":"

$\"Abbisko\"$

"}}],["$","div","2",{"dangerouslySetInnerHTML":{"__html":"

Founded in April 2016, Abbisko is an oncology focused biopharmaceutical company dedicated to discover and develop innovative medicines for unmet medical needs in China and around the world.

"}}],["$","div","3",{"dangerouslySetInnerHTML":{"__html":"

Industry	Healthcare
Invested	Jan 2021
Status	Current
Website	http://www.abbisko.com/

"}}]]}]}]}],[]]}]}]}]]}]